These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36899192)

  • 21. Fluoxetine improves functional work capacity in women with premenstrual dysphoric disorder.
    Steiner M; Brown E; Trzepacz P; Dillon J; Berger C; Carter D; Reid R; Stewart D
    Arch Womens Ment Health; 2003 Feb; 6(1):71-7. PubMed ID: 12715267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of competitive sports on menstrual cycle and menstrual disorders, including premenstrual syndrome, premenstrual dysphoric disorder and hormonal imbalances.
    Czajkowska M; Drosdzol-Cop A; Naworska B; Galazka I; Gogola C; Rutkowska M; Skrzypulec-Plinta V
    Ginekol Pol; 2020; 91(9):503-512. PubMed ID: 33030729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder.
    Dubol M; Wikström J; Lanzenberger R; Epperson CN; Sundström-Poromaa I; Comasco E
    Sci Rep; 2022 Apr; 12(1):5996. PubMed ID: 35397641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Luteal serum BDNF and HSP70 levels in women with premenstrual dysphoric disorder.
    Oral E; Ozcan H; Kirkan TS; Askin S; Gulec M; Aydin N
    Eur Arch Psychiatry Clin Neurosci; 2013 Dec; 263(8):685-93. PubMed ID: 23455589
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of premenstrual dysphoric disorder with the GABA
    Bixo M; Ekberg K; Poromaa IS; Hirschberg AL; Jonasson AF; Andréen L; Timby E; Wulff M; Ehrenborg A; Bäckström T
    Psychoneuroendocrinology; 2017 Jun; 80():46-55. PubMed ID: 28319848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.
    Yen JY; Lin HC; Lin PC; Liu TL; Long CY; Ko CH
    Int J Environ Res Public Health; 2019 Nov; 16(22):. PubMed ID: 31703451
    [No Abstract]   [Full Text] [Related]  

  • 28. Acupuncture and acupressure for premenstrual syndrome.
    Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Depressive mood and frontal alpha asymmetry during the luteal phase in premenstrual dysphoric disorder.
    Lin IM; Tsai YC; Peper E; Yen CF
    J Obstet Gynaecol Res; 2013 May; 39(5):998-1006. PubMed ID: 23551544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using daily ratings to confirm premenstrual syndrome/late luteal phase dysphoric disorder. Part I. Effects of demand characteristics and expectations.
    Gallant SJ; Popiel DA; Hoffman DM; Chakraborty PK; Hamilton JA
    Psychosom Med; 1992; 54(2):149-66. PubMed ID: 1565753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating biological rhythms disruptions across the menstrual cycle in women with comorbid bipolar disorder and premenstrual dysphoric disorder.
    El Dahr Y; de Azevedo Cardoso T; Syan SK; Caropreso L; Minuzzi L; Smith M; Allega OR; El-Tayebani M; Mendes-Ribeiro J; de Mattos Souza LD; da Silva RA; Mondin TC; Moreira FP; Kapczinski F; Jansen K; Frey BN
    Arch Womens Ment Health; 2022 Apr; 25(2):345-353. PubMed ID: 35226173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premenstrual disorders and rumination.
    Craner JR; Sigmon ST; Martinson AA; McGillicuddy ML
    J Clin Psychol; 2014 Jan; 70(1):32-47. PubMed ID: 23798035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of lifetime self-injurious thoughts and behaviors in a global sample of 599 patients reporting prospectively confirmed diagnosis with premenstrual dysphoric disorder.
    Eisenlohr-Moul T; Divine M; Schmalenberger K; Murphy L; Buchert B; Wagner-Schuman M; Kania A; Raja S; Miller AB; Barone J; Ross J
    BMC Psychiatry; 2022 Mar; 22(1):199. PubMed ID: 35303811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No Menstrual Cyclicity in Mood and Interpersonal Behaviour in Nine Women with Self-Reported Premenstrual Syndrome.
    Bosman RC; Albers CJ; de Jong J; Batalas N; Aan Het Rot M
    Psychopathology; 2018; 51(4):290-294. PubMed ID: 29874668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind study on efficacy and safety of sepranolone in premenstrual dysphoric disorder.
    Bäckström T; Ekberg K; Hirschberg AL; Bixo M; Epperson CN; Briggs P; Panay N; O'Brien S
    Psychoneuroendocrinology; 2021 Nov; 133():105426. PubMed ID: 34597899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Premenstrual syndrome and premenstrual dysphoric disorder].
    Kovács Z; Hegyi G; Szőke H
    Orv Hetil; 2022 Jun; 163(26):1023-1031. PubMed ID: 35895486
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychological performance across the menstrual cycle in women with and without Premenstrual Dysphoric Disorder.
    Resnick A; Perry W; Parry B; Mostofi N; Udell C
    Psychiatry Res; 1998 Feb; 77(3):147-58. PubMed ID: 9707297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.